HROW Harrow Corp Expected net earnings per share growth this year

Harrow, Inc. is scaling its ophthalmology product portfolio, targeting international growth and the expansion of pharmacy channels. Comparable earnings per share growth year-over-year illustrates the cash flow dynamics, where the -158.10 level indicates the parameter's status. Business stability is underpinned by unique postoperative formulations and an ESG approach to manufacturing that minimizes environmental impact during drug filling.

HROW (Harrow) Earnings growth in current year history from 07/04/2022 to 11/14/2026

Analytical breakdowns and data insights for company Harrow (HROW)

- stock value and consensus price forecast:

Market Price Harrow Corp|HROW - Price Target Chart

- market capitalization data:

Market Capitalization Harrow|HROW - Enterprise Value

- shareholders' equity book value data:

Accounting Value of a Share Harrow|HROW - Book Capitalization|Market Capitalization to Book Value Ratio harrowinc.com|HROW - Aggregate Company Assets

- debt burden and liquidity indicators:

- net income and valuation multiples indicators:

HROW - Net Profit|Company Profit Forecast Harrow, Inc.|HROW - Price to Earnings Ratio|Price to Future Earnings Ratio Harrow, Inc.|HROW - PEG Multiple|Enterprise Value to EBITDA Ratio Harrow Inc|HROW - Operating profit before deduction of amortization|Net earnings per share for the last four quarters Harrow|HROW - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months harrowinc.com|HROW - Earnings per share growth in current year|Expected earnings per share trend next year Harrow, Inc.

- sales volume and revenue information:

HROW - Company Revenue|Company Expected Sales Volume Harrow, Inc.|HROW - Market Cap to Revenue|Forward Price-to-Revenue Multiple Harrow, Inc.

Basic company analysis:HROW Harrow, Inc.

For the ophthalmology business of Harrow, Inc. (HROW), the comparison of annual EPS growth on the GURU.Markets platform reflects the effectiveness of its expansion into the dry eye segment and the integration of acquired brands. This indicator measures the year-over-year percentage change in net profit per share, allowing investors to assess the scaling pace of operating profitability against the backdrop of market reach.

Key competitors